NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Eagle Pharmaceuticals, Inc. Shareholders who purchased shares of EGRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
Month: January 2024
NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Generac Holdings, Inc.. Shareholders who purchased shares of GNRC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc.. Shareholders who purchased shares of INSP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of VNET Group, Inc.. Shareholders who purchased shares of VNET during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Mobileye Global Inc.. Shareholders who purchased shares of MBLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of ON Semiconductor Corporation. Shareholders who purchased shares of ON during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
SHANGHAI, Jan. 19, 2024 /PRNewswire/ — Yum China Holdings, Inc. (the “Company” or “Yum China”, NYSE: YUMC and HKEX: 9987) has been named by the Top Employers Institute as a Top Employer China for the sixth consecutive year. Ranked fourth overall among more than 150 companies included in…
STOCKHOLM, Jan. 19, 2024 /PRNewswire/ — InDex Pharmaceuticals Holding AB (publ) (“InDex Pharmaceuticals”) today announced that remaining commitments for the company have been quantified, and the expected cash balance per March 31, 2024, amounts to SEK 180-190 million. The amount includes…
STOCKHOLM, Jan. 19, 2024 /PRNewswire/ — InDex Pharmaceuticals Holding AB (publ) (“InDex Pharmaceuticals”) today announced that remaining commitments for the company have been quantified, and the expected cash balance per March 31, 2024, amounts to SEK 180-190 million. The amount includes…
PARIS, Jan. 19, 2024 /PRNewswire/ — Sopra Steria, a major player in the European tech sector, has been selected, through its Aeroline vertical, to help European aeronautics giant Airbus modernise its engineering methods and tools. This strategic announcement bolsters Sopra Steria’s…